PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 9 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

15 May 2026

  1. (diff | hist) 10:15 Talk:Resin cleavage 537 +143 MassSpecMarv (talk | contribs) /* Distinctive masses */ new section
  2. (diff | hist) 09:25 Talk:Repackaging 537 +153 BalanceBirdie (talk | contribs) /* Not irregular */ new section
  3. (diff | hist) 09:15 Talk:Limit of detection 537 +154 ScopeSeverin (talk | contribs) /* Threshold table scope */ new section
  4. (diff | hist) 08:50 Talk:GLP-1 receptor 885 +163 ForestPlotFinn (talk | contribs) /* Heart-rate figure */ reply
  5. (diff | hist) 04:24 USP General Chapter 85 5,180 ±0 Chromatokid (talk | contribs) clarify that area percent is not mass percent [rollback]
  6. (diff | hist) 01:29 Placebo-adjusted effect 4,805 ±0 AnalyticalAnnie (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]
  7. (diff | hist) m b 01:23 Regulatory status by jurisdiction 4,444 ±0 CategoryBot (talk | contribs) bot: expand DOI to full citation [rollback]

14 May 2026

  1. (diff | hist) 16:18 SURPASS trial programme 5,078 ±0 AnalyticalAnnie (talk | contribs) add the trial acronym expansion at first use [rollback]
  2. (diff | hist) 15:33 Talk:GLP-1 receptor 674 +144 DataTableDunja (talk | contribs) /* Heart-rate figure */ new section
  3. (diff | hist) 15:07 Shanghai ERP Biotechnology 14,637 ±0 PancreasPru (talk | contribs) add the reception tally with its period and count stated [rollback]
  4. (diff | hist) 14:25 Talk:Subcutaneous injection 748 +132 SyringeSybille (talk | contribs) /* Needle length and intramuscular delivery */ reply
  5. (diff | hist) 10:50 Talk:Subcutaneous injection 537 +163 NurseNoteNessa (talk | contribs) /* Needle length and intramuscular delivery */ new section
  6. (diff | hist) 08:26 Talk:Syringe dead space 1,444 +127 CrossRefCleve (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  7. (diff | hist) 05:51 Preparative HPLC purification 4,882 ±0 CrudePeptidePearl (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  8. (diff | hist) 03:18 Shanghai Wibson Biotechnology 15,440 ±0 Compounding_Cate (talk | contribs) British spelling per PP:MOS [rollback]
  9. (diff | hist) 01:06 Xi'an Mokemei Biotechnology 15,421 ±0 ApoB_Aurelio (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]

13 May 2026

  1. (diff | hist) 22:11 Beta cell function 6,096 ±0 NPOV_Nadia (talk | contribs) add the enteroendocrine cell type responsible for secretion [rollback]
  2. (diff | hist) m b 21:34 Survodutide 5,445 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 19:40 GenScript Peptides 17,833 ±0 FerritinFay (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  4. (diff | hist) 15:43 Tirzepatide 8,037 ±0 INN_Ingrid (talk | contribs) move the trade-name history out of the lead and into §Regulatory history [rollback]
  5. (diff | hist) 13:50 Talk:Contraindications of incretin therapy 748 +68 ClinicCorrespondent (talk | contribs) /* Renal caution is indirect */ reply
  6. (diff | hist) 12:55 Talk:Survodutide 748 +122 TitrationTheo (talk | contribs) /* Longer escalation */ reply
  7. (diff | hist) 10:57 Peptide harm reduction 4,800 ±0 CustomsClarke (talk | contribs) add the note that price is not a proxy for quality [rollback]
  8. (diff | hist) 10:15 Talk:Contraindications of incretin therapy 537 +138 eGFR_Esme (talk | contribs) /* Renal caution is indirect */ new section
  9. (diff | hist) 09:25 Talk:Survodutide 537 +179 EscalationEira (talk | contribs) /* Longer escalation */ new section
  10. (diff | hist) 09:01 Talk:Syringe dead space 1,233 +198 UnitsUrsula (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  11. (diff | hist) 03:06 Cagrilintide 4,256 ±0 OrforglipronOona (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]
  12. (diff | hist) 02:58 Oral semaglutide 4,582 ±0 TirzTaxonomist (talk | contribs) fix the amino-acid substitution — position 8, not position 2 [rollback]

12 May 2026

  1. (diff | hist) 17:12 LEADER trial 4,799 ±0 PeakShapePol (talk | contribs) ce, tighten prose [rollback]
  2. (diff | hist) 14:00 Talk:Electrospray ionisation 748 +60 Chromatokid (talk | contribs) /* Ion suppression */ reply
  3. (diff | hist) 14:00 Talk:Sterility testing 748 +122 EndotoxinEd (talk | contribs) /* Method suitability */ reply
  4. (diff | hist) 13:39 Talk:Syringe dead space 1,022 +246 PlainNumbersPip (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ reply
  5. (diff | hist) m 11:37 Methionine oxidation 5,001 ±0 DiluentDiya (talk | contribs) expand §Detection and control [rollback]
  6. (diff | hist) 11:14 Talk:Syringe dead space 811 +160 CrossRefCleve (talk | contribs) /* Should this article carry the vial-yield table, or should the calculator? */ new section
  7. (diff | hist) 10:25 Talk:Electrospray ionisation 537 +161 NewLabNell (talk | contribs) /* Ion suppression */ new section
  8. (diff | hist) 10:20 Talk:Sterility testing 537 +159 NewLabNell (talk | contribs) /* Method suitability */ new section
  9. (diff | hist) 08:22 Syringe dead space 20,968 ±0 ParentCatPansy (talk | contribs) sentence case in headings per PP:MOS [rollback]

11 May 2026

  1. (diff | hist) m 21:33 Cold-chain freight 4,758 ±0 SupplyWatchSuri (talk | contribs) rm the vendor-specific packaging detail; not general enough for the article [rollback]
  2. (diff | hist) m b 16:29 Personal importation policy 4,121 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]
  3. (diff | hist) m 13:43 Customs seizure 4,785 ±0 Compounding_Cate (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  4. (diff | hist) 13:15 Talk:SUSTAIN trial programme 748 +104 TrialsTabitha (talk | contribs) /* Dose confusion with STEP */ reply
  5. (diff | hist) 12:25 Talk:Medutest 748 +142 ArchiveAudit (talk | contribs) /* Forgery caveat placement */ reply
  6. (diff | hist) 11:33 Talk:Temperature excursion 1,581 +211 ManualOfStyleMo (talk | contribs) /* Assessment sequence reads as a procedure */ reply
  7. (diff | hist) 10:49 STEP trial programme 5,534 ±0 SurmountSurma (talk | contribs) fix a dangling clause [rollback]
  8. (diff | hist) 09:40 Talk:Medutest 537 +193 ForgeryFinder (talk | contribs) /* Forgery caveat placement */ new section
  9. (diff | hist) 09:40 Talk:SUSTAIN trial programme 537 +151 SemaglutideSasha (talk | contribs) /* Dose confusion with STEP */ new section

10 May 2026

  1. (diff | hist) 23:28 Growth hormone secretagogue 4,613 ±0 StyleSheetSybil (talk | contribs) convert a hard-coded date to the house format [rollback]
  2. (diff | hist) m 21:25 Fasting insulin 4,198 ±0 Chromatokid (talk | contribs) space between number and unit per PP:MOS [rollback]
  3. (diff | hist) 13:50 Talk:Haemoglobin A1c 748 +102 A1c_Alder (talk | contribs) /* Variant interference */ reply
  4. (diff | hist) 10:15 Talk:Haemoglobin A1c 537 +150 TSH_Tallulah (talk | contribs) /* Variant interference */ new section
  5. (diff | hist) 09:05 Talk:Retatrutide 959 +98 AttributeAnders (talk | contribs) /* No reference standard — is that claim safe? */ reply
  6. (diff | hist) 08:44 Prescribing information 4,506 ±0 LabRangeLindy (talk | contribs) add the currency and the date to every price figure [rollback]
  7. (diff | hist) 07:55 List of GLP-1 receptor agonists 3,862 ±0 FiveOhThreeB (talk | contribs) add the date column so the entries can be ordered [rollback]
  8. (diff | hist) 05:49 Triple agonist 4,269 ±0 LeanMassLars (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  9. (diff | hist) m 05:28 SELECT trial 5,171 ±0 ITT_Imelda (talk | contribs) add the randomisation ratio [rollback]

9 May 2026

  1. (diff | hist) m 19:30 Janoshik Analytical 5,235 ±0 SVG_Solomon (talk | contribs) add the laboratory accreditation status, or say plainly that it is not stated [rollback]
  2. (diff | hist) 14:50 Talk:Reconstitution of lyophilised peptides 885 +123 LyophilLena (talk | contribs) /* Freezing reconstituted solutions */ reply
  3. (diff | hist) 14:22 Talk:Retatrutide 748 +253 Chromatokid (talk | contribs) /* No reference standard — is that claim safe? */ reply
  4. (diff | hist) m b 11:47 Sterility testing 4,776 ±0 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 11:25 Talk:Reconstitution of lyophilised peptides 674 +182 ColdChainCleo (talk | contribs) /* Freezing reconstituted solutions */ new section
  6. (diff | hist) 10:48 Talk:Retatrutide 537 +165 PrimarySrcPatia (talk | contribs) /* No reference standard — is that claim safe? */ new section
  7. (diff | hist) m b 10:46 Albumin binding half-life extension 6,399 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  8. (diff | hist) 09:07 Talk:Temperature excursion 1,370 +151 ToneTilda (talk | contribs) /* Assessment sequence reads as a procedure */ reply
  9. (diff | hist) m 04:55 Incretin effect 7,358 ±0 IpamorelinIsold (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  10. (diff | hist) m 03:57 Residual solvent 5,085 ±0 IsocraticIla (talk | contribs) add the repeatability figure with the number of injections [rollback]
  11. (diff | hist) 01:44 Qingdao Sigma Chemical 15,455 ±0 AttributeAnders (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]
  12. (diff | hist) m 00:47 Satiety signalling 5,593 ±0 Ref_Desk_Ron (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

8 May 2026

  1. (diff | hist) 19:29 PolyPeptide Group (Hangzhou) 18,363 ±0 TrialsTabitha (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  2. (diff | hist) 17:18 Number needed to treat 4,718 ±0 DataTableDunja (talk | contribs) the trial was open-label; the article implied blinding [rollback]
  3. (diff | hist) 14:22 Talk:Temperature excursion 1,159 +323 Hedgerow_Hal (talk | contribs) /* Assessment sequence reads as a procedure */ reply
  4. (diff | hist) 13:50 Talk:Amylin 748 +114 MolarMassMaeve (talk | contribs) /* Insulin-to-amylin ratio */ reply
  5. (diff | hist) 13:10 Talk:Custom peptide synthesis 748 +151 SPPS_Sorrel (talk | contribs) /* Declining to quote */ reply
  6. (diff | hist) 12:26 Insulin secretion 6,940 ±0 MassSpecMarv (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  7. (diff | hist) 11:22 Talk:Amylin 537 +133 PlainNumbersPip (talk | contribs) /* Insulin-to-amylin ratio */ new section
  8. (diff | hist) 10:44 Talk:Temperature excursion 948 +287 ToneTilda (talk | contribs) /* Assessment sequence reads as a procedure */ new section
  9. (diff | hist) 09:35 Talk:Custom peptide synthesis 537 +178 BalanceBirdie (talk | contribs) /* Declining to quote */ new section
  10. (diff | hist) 08:41 Talk:Trial data comparison 1,033 +120 ForestPlotFinn (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply
  11. (diff | hist) 05:05 Bachem Holding (Suzhou) 15,124 ±0 EmptyingElke (talk | contribs) add the transit window each regional warehouse serves [rollback]
  12. (diff | hist) 03:37 Dipeptidyl peptidase-4 7,022 ±0 Chromatokid (talk | contribs) the half-life given was for the intact peptide; label it [rollback]
  13. (diff | hist) 03:08 Glucose-dependent insulinotropic polypeptide 8,265 ±0 SatietySunniva (talk | contribs) add see also to the sister hormone [rollback]
  14. (diff | hist) 01:02 Sterile water for injection 4,738 ±0 GroupBuyGalen (talk | contribs) expand §What it does not provide [rollback]

7 May 2026

  1. (diff | hist) 23:55 Chinese Peptide Company 15,513 ±0 COA_Colwyn (talk | contribs) add the research-use-only statement to the lead rather than only the footer [rollback]
  2. (diff | hist) 17:12 Peptide supply chain 8,410 ±0 GHK_Gwendolen (talk | contribs) add the note that lyophilised material tolerates excursions better than solution [rollback]
  3. (diff | hist) 14:00 Talk:MOTS-c 748 +82 CrossRefCleve (talk | contribs) /* Assay comparability */ reply
  4. (diff | hist) 13:30 Talk:Counterfeit peptide 748 +162 LyophilLena (talk | contribs) /* Declared excipients */ reply
  5. (diff | hist) 13:14 Hubei Jianxiang Bioscience 14,855 ±0 PrimarySrcPatia (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  6. (diff | hist) m b 11:35 Multi-dose vial 24,688 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  7. (diff | hist) 10:25 Talk:MOTS-c 537 +148 AnalyticalAnnie (talk | contribs) /* Assay comparability */ new section
  8. (diff | hist) m 10:08 Aspiration risk under anaesthesia 4,681 ±0 SarcopeniaSefa (talk | contribs) add the rebound point with the follow-up study it comes from [rollback]
  9. (diff | hist) m b 10:06 Purity claim inflation 5,660 ±0 CategoryBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 09:45 Talk:Counterfeit peptide 537 +166 BalanceBirdie (talk | contribs) /* Declared excipients */ new section
  11. (diff | hist) 09:15 Talk:Trial data comparison 822 +256 TrialsTabitha (talk | contribs) /* Cross-trial tabulation and the estimand problem */ reply
  12. (diff | hist) 07:30 Sigma-Aldrich (Shanghai) Trading 18,641 ±0 VerifyVesna (talk | contribs) state the city and province of the registered address [rollback]
  13. (diff | hist) m 05:30 Custom peptide synthesis 4,773 ±0 PrepHPLC_Pia (talk | contribs) expand §Documentation for custom work [rollback]
  14. (diff | hist) m 02:26 Counterfeit peptide 5,488 ±0 TriumphThad (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

6 May 2026

  1. (diff | hist) 23:45 Certificate of analysis 10,014 ±0 VerifyFirstVida (talk | contribs) unpipe a link that did not need piping [rollback]
  2. (diff | hist) m b 20:42 AmbioPharm 17,173 ±0 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 18:59 ChinaPeptides 14,979 ±0 ReaderRosalie (talk | contribs) expand §Regulatory position and legal status [rollback]
  4. (diff | hist) 16:22 Injection site rotation 4,872 ±0 ExenatideEzra (talk | contribs) unpipe a link that did not need piping [rollback]
  5. (diff | hist) 14:19 SinoPep 18,360 ±0 ReportReaderRilla (talk | contribs) typo [rollback]